NCT03277924 2024-08-13ImmunoSarcGrupo Espanol de Investigacion en SarcomasPhase 1/2 Completed197 enrolled
NCT01154452 2018-08-15Vismodegib and Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced or Metastatic SarcomaNational Cancer Institute (NCI)Phase 1/2 Completed78 enrolled 11 charts